CLOZAPINE and PNEUMONIA

Overview

PNEUMONIA is the #11 most commonly reported adverse reaction for CLOZAPINE, manufactured by HLS Therapeutics (USA), Inc.. There are 3,191 FDA adverse event reports linking CLOZAPINE to PNEUMONIA. This represents approximately 1.5% of all 207,229 adverse event reports for this drug.

Patients taking CLOZAPINE who experience pneumonia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

PNEUMONIA is a less commonly reported adverse event for CLOZAPINE, but still significant enough to appear in the safety profile.

Other Side Effects of CLOZAPINE

In addition to pneumonia, the following adverse reactions have been reported for CLOZAPINE:

• NEUTROPENIA — 18,655 reports
• HOSPITALISATION — 12,101 reports
• DEATH — 11,402 reports
• SCHIZOPHRENIA — 4,547 reports
• WHITE BLOOD CELL COUNT INCREASED — 4,448 reports
• WHITE BLOOD CELL COUNT DECREASED — 4,368 reports
• NEUTROPHIL COUNT INCREASED — 4,117 reports
• DRUG INEFFECTIVE — 3,865 reports
• MALAISE — 3,705 reports
• OFF LABEL USE — 3,565 reports

Other Drugs Associated with PNEUMONIA

The following drugs have also been linked to pneumonia in FDA adverse event reports:

Does CLOZAPINE cause PNEUMONIA?

PNEUMONIA has been reported as an adverse event in 3,191 FDA reports for CLOZAPINE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is PNEUMONIA with CLOZAPINE?

PNEUMONIA accounts for approximately 1.5% of all adverse event reports for CLOZAPINE, making it a notable side effect.

What should I do if I experience PNEUMONIA while taking CLOZAPINE?

If you experience pneumonia while taking CLOZAPINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages